Xenex Announces StrikeForce Disinfection Service

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

June 22, 2020

Xenex notes as cities across Texas report a spike in the number of coronavirus cases, businesses and organizations are looking for strategies to combat the virus within their facilities.

Xenex Disinfection Services, the world leader in UV disinfection for healthcare facilities, today announced the launch of StrikeForce, an innovative disinfection service. For the first time, organizations can engage Xenex’s team of environmental disinfection experts on a project basis to utilize Xenex LightStrike Germ-Zapping Robots to kill harmful viruses, bacteria and spores that linger on commonly touched surfaces and pose a risk for disease transmission. StrikeForce is currently limited to engagements in Texas.

“The entire world is thinking about disease transmission as a result of the COVID-19 pandemic. We had numerous requests from businesses who wanted us to bring robots in and disinfect their facilities for them to help ensure that their environment was virus-free. In response to market demand, we developed the StrikeForce service to enable companies to provide their staff and clients peace of mind through innovative disinfection solutions with minimal downtime,” said Irene Hahn, vice president of sales for Xenex.

The LightStrike disinfection robot is proven to destroy Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in two minutes. Surfaces contaminated with COVID-19 pose a grave threat to the safety of healthcare workers, patients, frontline responders, military service members, cruise line passengers, hotel guests and citizens everywhere. Deactivating the COVID-19 virus on surfaces is a critical and necessary step to providing a safe environment as businesses reopen and people get back to work. Restaurants, car dealerships, hotels, office buildings, gyms, and many other spaces can benefit immediately from StrikeForce disinfection as the global pandemic demonstrates the need for quick and effective disinfection wherever people work, play, or live.

LightStrike Germ-Zapping Robots use a xenon lamp to generate bursts of high intensity, broad spectrum (200-315nm) ultraviolet (UV) light that’s more intense than sunlight. Different pathogens are susceptible to UVC light at different wavelengths. With broad spectrum germicidal light, Xenex LightStrike robots quickly deactivate viruses, bacteria and spores where they are most vulnerable without damaging materials or equipment.

Xenex is the world leader in UV disinfection for healthcare facilities and its LightStrike robots have been deployed in more than 500 healthcare facilities around the world, including HonorHealth, the Mayo Clinic, MD Anderson Cancer Center, Stanford, and USC. The robots work quickly and do not require warm-up or cool-down time, so facilities are able to disinfect dozens of rooms per day (per robot). Hospitals have published peer-reviewed studies showing significant reductions in Clostridium difficile (C.diff), MRSA, VRE and/or Surgical Site Infection (SSI) rates after integrating Xenex’s infection prevention programs and using LightStrike robots to supplement their environmental disinfection efforts.

spot_img

DON'T MISS

Related Articles